Exclusives

ICYMI: Top Content from August 2023 on NutraceuticalsWorld.com

Our most-viewed stories in August included NOW’s quality testing, a couple of big acquisitions and more.

NOW Finds Quality Issues Abound in Astaxanthin Supplements
In its 15th round of testing products purchased online, the company tested products purchased on Walmart’s online platform.

Thorne HealthTech Agrees to Acquisition by Investment Firm for $10.20 Per Share
Transaction valued at approximately $680 million; Thorne would become a privately held company.

Designs for Health Launches Women’s Health Supplements
The brand has introduced a probiotic for vaginal and GI health and a phytoestrogen blend.

Wiley’s Finest Introduces Algae/Ahiflower Omega-3 Gummy
The latest offering follows the company’s first plant-based product line, Catchfree, which was launched in 2020.

Monster Beverage Acquires Bang Energy for $362 Million
Deal follows bankruptcy filing of Vital Pharmaceuticals in October 2022.

Saw Palmetto Extract Quality on the Market is Highly Variable: Study
Only a small portion of extracts tested passed USP monograph testing.

JAMA Report Criticizes Health Claims on Fish Oil Products
The authors, critical of structure/function claims, called for stricter labeling regulation.

NPA Submits Citizen Petition on Labeling of Mushrooms and Mycelia
The trade association is the latest authority to weigh in on a growing debate over nomenclature.

Irregular Sleep Impacts the Gut Microbiome
Unfavorable bacteria species were more abundant in people whose sleeping times were less consistent day-to-day.

Lisa Thomas Joins Nuherbs as Chief Commercialization Officer
Over her career, Thomas specialized in product development, sports nutrition, portfolio management, and health and safety compliance.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters